X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18904) 18904
Newsletter (170) 170
Magazine Article (152) 152
Newspaper Article (84) 84
Book Chapter (62) 62
Transcript (25) 25
Book / eBook (20) 20
Book Review (10) 10
Conference Proceeding (8) 8
Dissertation (5) 5
Publication (4) 4
Reference (3) 3
Government Document (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14749) 14749
serotonin uptake inhibitors - therapeutic use (10296) 10296
male (8651) 8651
female (8156) 8156
psychiatry (7574) 7574
adult (5802) 5802
pharmacology & pharmacy (5229) 5229
serotonin (4338) 4338
middle aged (4231) 4231
antidepressants (4022) 4022
neurosciences (3938) 3938
animals (3844) 3844
treatment outcome (3447) 3447
depression (3407) 3407
serotonin uptake inhibitors - adverse effects (3337) 3337
serotonin uptake inhibitors (3077) 3077
antidepressive agents - therapeutic use (2937) 2937
fluoxetine (2662) 2662
aged (2468) 2468
double-blind (2453) 2453
depressive disorder - drug therapy (2441) 2441
clinical neurology (2371) 2371
adolescent (2360) 2360
serotonin uptake inhibitors - pharmacology (2033) 2033
serotonin reuptake inhibitors (1933) 1933
depressive disorder, major - drug therapy (1881) 1881
rats (1783) 1783
major depression (1718) 1718
double-blind method (1675) 1675
drug therapy (1641) 1641
fluoxetine - therapeutic use (1566) 1566
depression - drug therapy (1538) 1538
depression, mental (1498) 1498
paroxetine (1377) 1377
dose-response relationship, drug (1366) 1366
research (1353) 1353
serotonin uptake inhibitors - administration & dosage (1331) 1331
serotonin - metabolism (1279) 1279
psychiatric status rating scales (1268) 1268
care and treatment (1262) 1262
major depressive disorder (1252) 1252
child (1234) 1234
sertraline (1228) 1228
risk factors (1221) 1221
efficacy (1205) 1205
anxiety (1201) 1201
citalopram - therapeutic use (1189) 1189
analysis (1185) 1185
psychology, clinical (1160) 1160
drug therapy, combination (1149) 1149
brain (1134) 1134
antidepressive agents, tricyclic - therapeutic use (1124) 1124
antidepressive agents, second-generation - therapeutic use (1067) 1067
mental depression (1067) 1067
antidepressive agents - adverse effects (1046) 1046
citalopram (1036) 1036
dopamine (1036) 1036
comorbidity (1034) 1034
paroxetine - therapeutic use (1027) 1027
mice (1026) 1026
young adult (993) 993
obsessive-compulsive disorder (992) 992
time factors (983) 983
drugs (973) 973
medicine, general & internal (969) 969
antidepressant (933) 933
obsessive-compulsive disorder - drug therapy (926) 926
severity of illness index (900) 900
health aspects (879) 879
placebo (861) 861
sertraline - therapeutic use (843) 843
drug interactions (842) 842
pharmacology (835) 835
medicine & public health (832) 832
risk (789) 789
placebo-controlled trial (784) 784
antidepressive agents - pharmacology (783) 783
randomized controlled trials as topic (774) 774
antipsychotic agents - therapeutic use (771) 771
rats, sprague-dawley (758) 758
prevalence (757) 757
pharmacotherapy (754) 754
pharmacology/toxicology (752) 752
depressive disorder - psychology (741) 741
drug administration schedule (730) 730
psychology (728) 728
children (726) 726
neurology (726) 726
combined modality therapy (719) 719
pregnancy (719) 719
venlafaxine hydrochloride (713) 713
clinical trials (708) 708
ssri (704) 704
psychotherapy (695) 695
mental disorders (692) 692
cognitive therapy (686) 686
brain - drug effects (683) 683
anxiety disorders - drug therapy (672) 672
fluvoxamine (668) 668
disease models, animal (663) 663
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Mississauga - Stacks (3) 3
Online Resources - Online (2) 2
University College (Laidlaw) - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Periodical Stacks (1) 1
Scarborough Hospital - General (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18668) 18668
German (243) 243
French (158) 158
Japanese (155) 155
Spanish (93) 93
Russian (82) 82
Dutch (52) 52
Danish (37) 37
Polish (35) 35
Swedish (35) 35
Portuguese (34) 34
Italian (27) 27
Chinese (25) 25
Norwegian (24) 24
Hungarian (23) 23
Finnish (18) 18
Hebrew (10) 10
Icelandic (5) 5
Turkish (4) 4
Croatian (3) 3
Bulgarian (2) 2
Czech (2) 2
Greek (2) 2
Korean (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane library, ISSN 1465-1858, 2012, Volume 2012, Issue 11, p. CD004851
.... Newer generation antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs... 
Intervention | Condition | Paroxetine | SSRIs | Fluoxetine | Mental health | Induction Chemotherapy | Depressive disorder, major | Depression | Depressive Disorder | Antidepressive Agents | Suicide | Depressive disorders & major depression | Sertraline | Citalopram | Randomized Controlled Trials as Topic | Antidepressants | Child health | Mood disorders | Population | Child & Adolescent | Exclusively child and/or adolescent poopulation | Medicine General & Introductory Medical Sciences | Serotonin Uptake Inhibitors | Fluoxetine [adverse effects; therapeutic use] | RISK-FACTORS | Humans | SUICIDAL IDEATION | Citalopram [administration & dosage; therapeutic use] | Depressive Disorder [drug therapy; psychology] | MAJOR DEPRESSION | Sertraline [administration & dosage; therapeutic use] | PHARMACOLOGICAL-TREATMENT | PULSE CLOMIPRAMINE | SEROTONIN REUPTAKE INHIBITORS | MEDICINE, GENERAL & INTERNAL | Suicide [psychology] | COGNITIVE-BEHAVIORAL THERAPY | Paroxetine [adverse effects; therapeutic use] | Adolescent | TERM FOLLOW-UP | DOUBLE-BLIND | Antidepressive Agents [adverse effects; therapeutic use] | Serotonin Uptake Inhibitors [adverse effects; therapeutic use] | PLACEBO-CONTROLLED TRIAL | Child | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Depressive Disorder - drug therapy | Paroxetine - therapeutic use | Paroxetine - adverse effects | Antidepressive Agents - therapeutic use | Citalopram - administration & dosage | Sertraline - administration & dosage | Sertraline - therapeutic use | Suicide - psychology | Citalopram - therapeutic use | Antidepressive Agents - adverse effects | Depressive Disorder - psychology | Fluoxetine - therapeutic use | Fluoxetine - adverse effects
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2006, Volume 354, Issue 12, pp. 1243 - 1252
Journal Article
Cochrane library, ISSN 1469-493X, 02/2018, Volume 2020, Issue 7, p. CD010292
Journal Article
Psychopharmacology, ISSN 1432-2072, 2011, Volume 219, Issue 2, pp. 313 - 326
... of impulsivity.The effects of selective DA (GBR12909; 2.5–10 mg/kg), NA (atomoxetine; 0.3–3.0 mg/kg) and 5-HT (citalopram; 0.3–3.0 mg/kg) reuptake inhibitors as well as amphetamine... 
Econometric and Statistical Methods: General | Geneeskunde (GENK) | Bescherming en bevordering van de menselijke gezondheid | Medical sciences | Geneeskunde(GENK) | Neurosciences | Impulsivity | Biomedicine | Dopamine | Serotonin | Delayed reward | Pharmacology/Toxicology | Psychiatry | Noradrenaline | Five-choice serial reaction time task | PSYCHIATRY | GLOBAL 5-HT DEPLETION | DEFICIT-HYPERACTIVITY DISORDER | TERM ATOMOXETINE TREATMENT | NEUROSCIENCES | REACTION-TIME-TASK | PREFRONTAL CORTEX | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | RESPONSE-INHIBITION | NUCLEUS-ACCUMBENS CORE | NOREPINEPHRINE TRANSPORTER | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | Citalopram - pharmacology | Dopamine Uptake Inhibitors - therapeutic use | Male | Dose-Response Relationship, Drug | Time Factors | Reaction Time - drug effects | Atomoxetine Hydrochloride | Serial Learning - drug effects | Animals, Outbred Strains | Choice Behavior - drug effects | Adrenergic Uptake Inhibitors - therapeutic use | Dopamine Uptake Inhibitors - pharmacology | Amphetamine - therapeutic use | Amphetamine - pharmacology | Serotonin Uptake Inhibitors - therapeutic use | Rats | Piperazines - therapeutic use | Piperazines - pharmacology | Animals | Propylamines - therapeutic use | Adrenergic Uptake Inhibitors - pharmacology | Citalopram - therapeutic use | Impulsive Behavior - drug therapy | Propylamines - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Antidepressants | Mental illness | Neurotransmitters | Inhibitor drugs | Response time | Animal behavior | Rodents | Psychopharmacology | Drug abuse | Drug addiction | Mental disorders | Attention deficit hyperactivity disorder | impulsive behavior | Drug delivery | Personality | Reaction time task | Intertrial interval | Amphetamine | Affective disorders | Reinforcement | Norepinephrine | citalopram | Neurotransmission | monoamines | Original Investigation
Journal Article
Neurology, ISSN 1526-632X, 2006, Volume 67, Issue 8, pp. 1411 - 1420
...: To assess the efficacy of duloxetine, a dual reuptake inhibitor of 5-HT and NE, on the reduction of pain severity, as well as secondary outcome measures in patients with diabetic peripheral neuropathic pain (DPNP). Methods... 
NOREPINEPHRINE REUPTAKE INHIBITOR | EFFICACY | PERSISTENT PAIN | DOUBLE-BLIND | MAJOR DEPRESSIVE DISORDER | PLACEBO-CONTROLLED TRIAL | EXTENDED-RELEASE | CLINICAL NEUROLOGY | IMIPRAMINE TREATMENT | DUAL-SEROTONIN | VENLAFAXINE | Diabetic Neuropathies - blood | Thiophenes - therapeutic use | Humans | Middle Aged | Acetaminophen - administration & dosage | Male | Palliative Care | Peripheral Nervous System Diseases - physiopathology | Thiophenes - administration & dosage | Thiophenes - blood | Peripheral Nervous System Diseases - blood | Female | Serotonin Uptake Inhibitors - blood | Adrenergic Uptake Inhibitors - blood | Acetaminophen - therapeutic use | Neuralgia - physiopathology | Drug Therapy, Combination | Diabetic Neuropathies - physiopathology | Severity of Illness Index | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Drug Administration Schedule | Serotonin Uptake Inhibitors - therapeutic use | Treatment Outcome | Analgesics, Non-Narcotic - administration & dosage | Diabetic Neuropathies - drug therapy | Analgesics, Non-Narcotic - therapeutic use | Neuralgia - drug therapy | Norepinephrine - metabolism | Neuralgia - blood | Serotonin Uptake Inhibitors - administration & dosage | Pain - physiopathology | Adrenergic Uptake Inhibitors - administration & dosage | Duloxetine Hydrochloride | Aged | Peripheral Nervous System Diseases - drug therapy
Journal Article
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 04/2012, Volume 19, Issue 12, pp. 1846 - 1863
...., selective serotonin reuptake inhibitors (SSRIs), which are still the most prescribed and widely used ones... 
Paroxetine | Antidepressants | Fluoxetine | Pharmacological properties | Selective serotonin reuptake inhibitors (SSRIs) | Therapeutic drug monitoring (TDM) | Vilazodone | Fluvoxamine | Sertraline | Chemical-clinical correlations | Citalopram | ELECTRON-CAPTURE DETECTION | POSTTRAUMATIC-STRESS-DISORDER | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | fluvoxamine | TANDEM MASS-SPECTROMETRY | pharmacological properties | OBSESSIVE-COMPULSIVE DISORDER | PERFORMANCE LIQUID-CHROMATOGRAPHY | chemical-clinical correlations | therapeutic drug monitoring (TDM) | fluoxetine | paroxetine | selective serotonin reuptake inhibitors (SSRIs) | PHARMACOLOGY & PHARMACY | MAJOR DEPRESSIVE DISORDER | PLACEBO-CONTROLLED TRIAL | NEW-GENERATION ANTIDEPRESSANTS | citalopram | TRANSPORTER BINDING PROFILE | vilazodone | sertraline | SOLID-PHASE EXTRACTION | Paroxetine - pharmacokinetics | Serotonin Uptake Inhibitors - pharmacokinetics | Fluoxetine - pharmacokinetics | Humans | Citalopram - adverse effects | Depressive Disorder - drug therapy | Paroxetine - therapeutic use | Sertraline - adverse effects | Paroxetine - adverse effects | Benzofurans - pharmacokinetics | Sertraline - pharmacokinetics | Vilazodone Hydrochloride | Sertraline - therapeutic use | Fluoxetine - therapeutic use | Piperazines - pharmacokinetics | Fluoxetine - adverse effects | Fluvoxamine - therapeutic use | Benzofurans - therapeutic use | Serotonin Uptake Inhibitors - therapeutic use | Fluvoxamine - pharmacokinetics | Serotonin Uptake Inhibitors - adverse effects | Piperazines - therapeutic use | Benzofurans - adverse effects | Depressive Disorder - metabolism | Fluvoxamine - adverse effects | Piperazines - adverse effects | Indoles - adverse effects | Citalopram - pharmacokinetics | Citalopram - therapeutic use | Indoles - pharmacokinetics | Indoles - therapeutic use | Drug Monitoring
Journal Article
Journal Article